The global sterile medical packaging market is anticipated to grow at a 6.2% CAGR during 2021-2027 and will reach USD 47.3 billion by 2027. Factors attributing to the growth of the sterile medical packaging market include mounting development of the healthcare industry, increased prominence of geriatric population, rising demand for medical devices and surgical equipment globally, increased initiatives by consumers, governments, and manufacturers to increase the level of infection control, favorable healthcare policies will propel the growth of the market. Nevertheless, the increasing growth of novel sustainable packaging solutions and the rising prevalence of chronic diseases will offer tremendous opportunities in the global sterile medical packaging market.

The COVID-19 pandemic had a positive impact on the sterile medical packaging market owing to the spread of infectious and communicable diseases, resulting in the need to have proper hygiene in medical devices so as to prevent contamination and spread of the disease. There is an increased demand for masks, devices, medical supplies, syringes, etc. that has led to growth in primary and secondary packaging.

Download Free Sample Copy Of Research Report: https://www.vynzresearch.com/healthcare/sterile-medical-packaging-market/request-sample

The global sterile medical packaging market is segmented into thermoform trays, sterile bottles & containers, vials & ampoules, pre-fillable inhalers, sterile closures, pre-filled syringes, blister & clamshells, bags & pouches, and wraps, according to type. Thermoform trays are anticipated to have a high CAGR during the forecast period because of their lightweight, are adaptable, and easy to move. Thermoformed trays are plastic trays that come in various shapes and sizes. They are also equipped for interior usage and are used to pack sutures, testing kits, implants, and sensitive surgical items.

North America held the highest share of the market and is predicted to grow at the fastest rate during the forecast period. This expansion can be ascribed to the regulation imposed by FDA, which are boosting the need for sustainable and high-quality products in this region. Furthermore, the industry has become extremely competitive in the region as a result of the presence of several significant competitors and strict FDA restrictions along with the rising pharmaceutical industry, the increased number of patients suffering from coronavirus will fuel the growth in the region.

In June 2021, Amcor has introduced a multi-chamber pouch designed specifically for drug-device combination products. The Dual Chamber Pouch, which is now available in Europe for the first time, has already received a 2021 Award from the Flexible Packaging Association for its technical innovation and material structure.

The prominent players in the sterile medical packaging industry include GS Medical Packaging, Amcor Plc, Placon, Oliver Healthcare Packaging, DuPont, Steripack Ltd., Wipak Group, Nelipak Healthcare, Tekni-Plex, Sonoco, BillerudKorsnäs AB, ProAmpac, West Pharmaceutical Services, Inc., Riverside Medical Packaging Company Ltd, Orchid, and Techinipaq Inc.

Source: VynZ Research